
### [MONDO:0018033](http://purl.obolibrary.org/obo/MONDO_0018033)
**Label:** other immunodeficiency syndromes due to defects in innate immunity

**Subclasses:** [MONDO:0009176](http://purl.obolibrary.org/obo/MONDO_0009176) (epidermodysplasia verruciformis), [MONDO:0010066](http://purl.obolibrary.org/obo/MONDO_0010066) (familial isolated congenital asplenia), [MONDO:0008674](http://purl.obolibrary.org/obo/MONDO_0008674) (WHIM syndrome), [MONDO:0010587](http://purl.obolibrary.org/obo/MONDO_0010587) (epidermodysplasia verruciformis, X-linked), [MONDO:0017925](http://purl.obolibrary.org/obo/MONDO_0017925) (T-cell immunodeficiency with epidermodysplasia verruciformis), 

**Corr. equiv. classes:** [OMIM:271400](http://purl.obolibrary.org/obo/OMIM_271400), [Orphanet:101351](http://www.orpha.net/ORDO/Orphanet_101351), [OMIM:193670](http://purl.obolibrary.org/obo/OMIM_193670), [Orphanet:324294](http://www.orpha.net/ORDO/Orphanet_324294), [OMIM:305350](http://purl.obolibrary.org/obo/OMIM_305350), [Orphanet:51636](http://www.orpha.net/ORDO/Orphanet_51636), [OMIM:226400](http://purl.obolibrary.org/obo/OMIM_226400), [Orphanet:302](http://www.orpha.net/ORDO/Orphanet_302), 

**Class expressions from DL-Learner:**

- [HP:0002860](http://purl.obolibrary.org/obo/HP_0002860) (Squamous cell carcinoma) and [HP:0200043](http://purl.obolibrary.org/obo/HP_0200043) (Verrucae) 53.32%
- [HP:0200043](http://purl.obolibrary.org/obo/HP_0200043) (Verrucae) 42.77%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 32.39%
- Thing 32.39%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 32.39%
- [HP:0008069](http://purl.obolibrary.org/obo/HP_0008069) (Neoplasm of the skin) 25.13%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 21.68%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 21.54%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 20.73%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 20.42%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 20.24%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 19.90%
- [HP:0003593](http://purl.obolibrary.org/obo/HP_0003593) (Infantile onset) 16.51%
- [HP:0003674](http://purl.obolibrary.org/obo/HP_0003674) (Onset) 14.90%
- [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 14.39%


